Chlamydia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Immunogenicity of a Chlamydia Vaccine CTH522
Condition:   Trachoma Interventions:   Biological: CTH522-CAF01 IM;   Biological: CTH522-CAF09b IM;   Biological: CTH522 ID;   Biological: CTH522 TO;   Biological: Placebo (Saline) Sponsors:   Statens Serum Institut;   Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2019 Category: Research Source Type: clinical trials